{"transactions":[{"id":811330,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-09T21:15:07.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":8789,"price":2.56,"value":22499.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of 50% of an annual cash retainer for service on the Issuer's Board of Directors in the aggregate amount of $22,500. The RSUs vest 25% upon grant and 25% on each of June 30, 2026, September 30, 2026 and December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":8789,"source":{"system":"sec-edgar","filing":"0001368324-26-000004","document":"form4-04092026_050403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000136832426000004/form4-04092026_050403.xml","form_type":"4"}},{"id":873680,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-02T21:30:16.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 26, 2027, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":1.65,"expiration_date":"2036-02-25","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001368324-26-000002","document":"form4-03022026_040311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000136832426000002/form4-03022026_040311.xml","form_type":"4"}},{"id":1106028,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-18T20:45:09.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 20, 2026, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-25-017697","document":"form4-06182025_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000141588925017697/form4-06182025_040606.xml","form_type":"4"}},{"id":1330591,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:15:19.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date."}],"balance_after":90000,"derivative":{"exercise_price":1.06,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-24-029473","document":"form4-12162024_041215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000141588924029473/form4-12162024_041215.xml","form_type":"4"}},{"id":1618867,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T22:57:32.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.68,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-24-003962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919124003962/doc4.xml","form_type":"4"}},{"id":1989841,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T21:55:52.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-02-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-013229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919123013229/doc4.xml","form_type":"4"}},{"id":2298253,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:53:40.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":69424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":69424,"derivative":{"exercise_price":3.22,"expiration_date":"2032-04-07","underlying":"Common Stock","underlying_shares":69424},"source":{"system":"sec-edgar","filing":"0001209191-22-024198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919122024198/doc4.xml","form_type":"4"}},{"id":2411457,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-05T01:50:34.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-007328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919122007328/doc4.xml","form_type":"4"}},{"id":2671485,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:22:36.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.49,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-040075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919121040075/doc4.xml","form_type":"4"}},{"id":2707377,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-19T01:00:58.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":1750,"derivative":{"exercise_price":3.67,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001209191-21-033829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919121033829/doc4.xml","form_type":"4"}},{"id":3118258,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T21:38:19.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":13250,"derivative":{"exercise_price":5.29,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0001209191-20-035040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919120035040/doc4.xml","form_type":"4"}},{"id":3369656,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-15T21:26:09.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":7437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":7437,"derivative":{"exercise_price":2.43,"expiration_date":"2029-11-12","underlying":"Common Stock","underlying_shares":7437},"source":{"system":"sec-edgar","filing":"0001209191-19-056745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919119056745/doc4.xml","form_type":"4"}},{"id":3448812,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-03T00:28:45.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":5813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":5813,"derivative":{"exercise_price":1.65,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":5813},"source":{"system":"sec-edgar","filing":"0001209191-19-044363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919119044363/doc4.xml","form_type":"4"}},{"id":3899601,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T21:43:56.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":5813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":5813,"derivative":{"exercise_price":8.12,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":5813},"source":{"system":"sec-edgar","filing":"0001209191-18-036751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368324/000120919118036751/doc4.xml","form_type":"4"}},{"id":4260139,"issuer":{"id":131428,"kind":"organization","name":"Allied World Assurance Co Holdings, GmbH"},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-07-10T16:47:56.000Z","date":"2017-07-06","kind":"other","acquired":false,"shares":43727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of in an exchange offer by a wholly-owned subsidiary of Fairfax Financial Holdings Limited, a Canadian corporation (\"Fairfax\"), to acquire all of the outstanding common shares, par value CHF 4.10 per share, of the Issuer, pursuant to the terms, and subject to the conditions, of that certain Agreement and Plan of Merger, dated as of December 18, 2016, between Fairfax and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of the Issuer was exchanged for (i) cash consideration of $23.00, (ii) a special cash dividend of $5.00 and (iii) 0.057937 of a share of subordinate voting stock of Fairfax."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-044611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1163348/000120919117044611/doc4.xml","form_type":"4"}},{"id":4424923,"issuer":{"id":131428,"kind":"organization","name":"Allied World Assurance Co Holdings, GmbH"},"owners":[{"id":53061,"kind":"person","name":"Friedman Bart","position":1,"cik":"0001368324","reported_name":"Friedman Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-02-24T16:29:18.000Z","date":"2017-02-22","kind":"tax_withholding","acquired":false,"shares":548,"price":53.12,"value":29109.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exclusively represents shares withheld by the Company with respect to the payment of Swiss withholding tax liability incurred upon the vesting of Restricted Stock Units."}],"balance_after":43727,"source":{"system":"sec-edgar","filing":"0001209191-17-014331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1163348/000120919117014331/doc4.xml","form_type":"4"}}]}